Clinical Trial Update: Flow Regulation by Opening the SepTum in Patients With Heart Failure; a Prospective, Randomized, Sham-controlled, Double-blind, Global Multicenter Study [NA]

View source ↗

Summary

A prospective randomized, sham-controlled global trial sponsored by Occlutech International AB is evaluating flow regulation by opening the SepTum in heart fail…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Heart Failure with Reduced Ejection Fraction

Drugs mentioned

• SepTum Flow Regulation Device

Snippet

Sponsor: Occlutech International AB | Conditions: Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Reduced Ejection Fraction (HFrEF) | NA | Status: ACTIVE_NOT_RECRUITING